JDRF welcomes Disability Advisory Committee's recommendation that all Canadians needing life-sustaining therapy should automatically meet the criteria for the Disability Tax Credit and urges the Government to adopt this approach
JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, welcomes the release of the Disability Advisory Committee’s (DAC) Firs...Read More
JDRF Canada awards $466,450 (USD) to Dr. Ahmad Haidar and his team at McGill University to improve the artificial pancreas system
JDRF Canada awards new research grant to Dr. Kieffer to explore new options for stem cell derived transplants for diabetes patients
JDRF Canada has made a major investment in accelerating type 1 diabetes research by awarding over $4M USD in grants to researchers across Canada.
JDRF will contribute up to $500,000 in funds to finance preclinical studies on the MAILPAN® bioartificial pancreas
Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes
$2.45 million USD awarded to advance Sernova’s Cell Pouch System(TM) (CPS) technologies in a US FDA Clinical Trial with Initiation Scheduled for the Second Half of 2016
JDRF presented three prestigious research awards to three experts whose groundbreaking research is accelerating life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications.
The JDRF Revolution Ride to Defeat Diabetes, presented by Sun Life Financial, is taking place through September and October in 19 cities across Canada and will engage over 15,000 people who are ready to make a difference for those living with type 1 diabetes (T1D).